MetaMorphix Starts Aquaculture Venture with Stirius | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Animal genetics companies MetaMorphix (MMI) and Stirius have teamed to form AquaAnimal Health, a joint venture that will use MMI's biomarker-based technology to sustain certain characteristics in aquaculture animals such as finfish and crustaceans.

Under the agreement, MMI has granted AcquAnimal Health a license to its proprietary Myostatin technology and an option to its Genius Whole Genome System for use in aquaculture applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.